APGE - CIK 0001974640
Apogee Therapeutics, Inc. has filed 262 documents with the SEC between 2023 and 2026. The most frequent type is insider trade (88 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2024-03-05 | 2024-03-05 |
| Major company event | 8-K | 2024-03-05 | 2024-03-05 |
| SEC correspondence | UPLOAD | 2024-02-29 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| DRS | - | 2024-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Insider trade | 4 | 2024-01-31 | 2024-01-29 |
| Activist ownership stake (update) | SC 13D/A | 2024-01-31 | - |
| Insider trade | 4 | 2023-12-20 | 2023-12-18 |
| Insider trade | 4 | 2023-12-20 | 2023-12-18 |
| Insider trade | 4 | 2023-12-20 | 2023-12-18 |
| Quarterly report | 10-Q | 2023-11-13 | 2023-09-30 |
| Major company event | 8-K | 2023-11-13 | 2023-11-13 |
| Passive ownership stake | SC 13G | 2023-11-03 | - |
| Quarterly report | 10-Q | 2023-08-28 | 2023-06-30 |
| Employee stock plan | S-8 | 2023-08-28 | - |
| Major company event | 8-K | 2023-08-28 | 2023-08-28 |
| Insider trade | 4 | 2023-08-21 | 2023-08-17 |
| New insider ownership | 3 | 2023-08-21 | 2023-08-17 |
| Major company event | 8-K | 2023-08-21 | 2023-08-17 |
| Passive ownership stake | SC 13G | 2023-08-10 | - |
| Major company event | 8-K | 2023-08-07 | 2023-08-07 |
| Activist ownership stake | SC 13D | 2023-07-28 | - |
| SEC STAFF LETTER | - | 2023-07-25 | - |
| Passive ownership stake | SC 13G | 2023-07-24 | - |
| Activist ownership stake | SC 13D | 2023-07-21 | - |
| Insider trade | 4 | 2023-07-17 | 2023-07-13 |
| Insider trade | 4 | 2023-07-17 | 2023-07-13 |
| Insider trade | 4 | 2023-07-17 | 2023-07-13 |
| 3/A | - | 2023-07-17 | 2023-07-13 |
| 3/A | - | 2023-07-17 | 2023-07-13 |
| 3/A | - | 2023-07-17 | 2023-07-13 |
| 3/A | - | 2023-07-17 | 2023-07-13 |
| 3/A | - | 2023-07-17 | 2023-07-13 |
| 424B4 | - | 2023-07-17 | - |
| EFFECT | - | 2023-07-13 | - |
| New insider ownership | 3 | 2023-07-13 | 2023-07-13 |
| New insider ownership | 3 | 2023-07-13 | 2023-07-13 |
| New insider ownership | 3 | 2023-07-13 | 2023-07-13 |
| New insider ownership | 3 | 2023-07-13 | 2023-07-13 |
| New insider ownership | 3 | 2023-07-13 | 2023-07-13 |
| New insider ownership | 3 | 2023-07-13 | 2023-07-13 |
| New insider ownership | 3 | 2023-07-13 | 2023-07-13 |
| New insider ownership | 3 | 2023-07-13 | 2023-07-13 |
| S-1MEF | - | 2023-07-13 | - |
| Exchange certification | CERT | 2023-07-12 | - |
| Company correspondence | CORRESP | 2023-07-11 | - |
| Company correspondence | CORRESP | 2023-07-11 | - |
| 8-A12B | - | 2023-07-10 | - |